Mastereksamen: Brage Milch Johannesen

TREM2: A potential target for treatment of Alzheimer’s Disease

Veileder: Lars Nilsson, Farmakologisk inst., Marianne Fyhn, IBV

Sensorer: Luisa Luna, OUS-RH, Kristian Lensjø, IBV

Publisert 3. juni 2019 10:32 - Sist endret 3. juni 2019 10:32